Immediate Impact
9 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
ALK-positive lung cancer: a moving target
2023 Standout
Works of Anna Morelli being referenced
ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Anna Morelli | 54 | 28 | 17 | 59 | 38 | 17 | 145 | |
| V. Hofmann | 42 | 24 | 49 | 76 | 22 | 18 | 200 | |
| Yana Novis | 75 | 20 | 37 | 24 | 28 | 12 | 165 | |
| Houra Loghmani | 34 | 35 | 66 | 26 | 41 | 15 | 199 | |
| Shu Zhang | 36 | 8 | 9 | 104 | 39 | 21 | 156 | |
| Chaosheng Deng | 12 | 60 | 16 | 113 | 42 | 23 | 202 | |
| Pavel Davizon‐Castillo | 20 | 39 | 56 | 42 | 12 | 18 | 157 | |
| R. Rajan | 21 | 14 | 22 | 42 | 70 | 13 | 171 | |
| Jan Hudeček | 21 | 19 | 70 | 77 | 18 | 14 | 181 | |
| Phoenix Bell | 43 | 12 | 14 | 26 | 17 | 19 | 136 | |
| Rikke Linnemann Nielsen | 23 | 33 | 13 | 15 | 11 | 13 | 146 |
All Works
Loading papers...